The tert-butyl dimethyl silyl group as an enhancer of drug cytotoxicity against human tumor cells

The synthesis of enantiomerically pure (2R,3S)-disubstituted tetrahydropyranes and their in vitro activity against HL60 promyelocytic leukemia cells and MCF7 breast cancer cells are reported. A structure-activity relationship is discussed.